Concepedia

Publication | Open Access

Cell Polarity Protein Pals1-Associated Tight Junction Expression Is a Favorable Prognostic Marker in Clear Cell Renal Cell Carcinoma

10

Citations

21

References

2020

Year

Abstract

<b>Introduction</b>: The Pals1-associated tight junction (PATJ) is a Crumbs (CRB) complex component that regulates epithelial cell apico-basal polarity and directional migration. This study assessed PATJ expression in clear cell renal cell carcinoma (ccRCC) vs. normal tissues and associated with ccRCC progression and prognosis. <b>Methods</b>: The effects of PATJ knockdown were investigated on regulation of normal kidney epithelial cell viability and protein expression <i>in vitro</i>. The <i>PATJ</i> mRNA data in ccRCC were obtained from The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) databases and analyzed with UALCAN, LinkedOmics, Kaplan-Meier Plotter, GEPIA, and SurvExpress tools. Immunohistochemistry was performed for PATJ in tissue microarray sections (<i>n</i> = 150 ccRCC and 30 normal renal specimens). Normal human kidney tubular epithelial cell (HKC) cells were transfected with <i>PATJ</i> and negative control siRNA for cell viability CCK-8 assay, flow cytometry, and western blots. <b>Results</b>: The data showed that <i>PATJ</i> mRNA and protein were downregulated in ccRCC tissues and cell lines. Downregulation of <i>PATJ</i> mRNA was associated with male patients, advanced tumor stages, grades, and ccB subtypes as well as poorer overall and disease-free survival of patients. Furthermore, PATJ protein was also significantly downregulated in ccRCC tissues and associated with advanced tumor pathologic, TNM stages and poorer overall. <i>In vitro</i>, knockdown of PATJ expression promoted HKC proliferation and the activation of mitogen-activated protein kinases (MAPK) pathway proteins. <b>Conclusions</b>: This study revealed that a decrease of PATJ in ccRCC, which was associated with male patients, advanced tumor, and poorer survival, suggesting that PATJ may be a useful prognostic biomarker and therapeutic target for ccRCC.

References

YearCitations

Page 1